Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report

por Jing, Wei, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2020

Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer

por Ma, Jie-Tao, Zheng, Jia-He, Han, Cheng-Bo, Guo, Qi-Yong
Publicado 2014

Response to “A meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer”

por Ma, Jie-tao, Han, Cheng-bo, Zheng, Jia-he, Guo, Qi-yong
Publicado 2015

Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis

por Zhang, Shu-Ling, Han, Cheng-Bo, Sun, Li, Huang, Le-Tian, Ma, Jie-Tao
Publicado 2020

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies

por Ma, Jietao, Sun, Xin, Huang, Letian, Xiong, Zhicheng, Yuan, Meng, Zhang, Shuling, Han, Cheng-Bo
Publicado 2016

Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysis

por Ma, Jie-Tao, Sun, Jing, Sun, Li, Zhang, Shu-Ling, Huang, Le-Tian, Han, Cheng-Bo
Publicado 2018

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized contr...

por Zhang, Shu-Ling, Yi, Xiao-Fang, Huang, Le-Tian, Sun, Li, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2023

The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs

por Sun, Li, Li, Yao-Yong, Ma, Jie-Tao, Zhang, Shu-Ling, Huang, Le-Tian, Han, Cheng-Bo
Publicado 2019

Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs

por Liu, Yang, Sun, Li, Xiong, Zhi-Cheng, Sun, Xin, Zhang, Shu-Ling, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2017

Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma

por Liu, Yang, Xiong, Zhi-Cheng, Sun, Xin, Sun, Li, Zhang, Shu-Ling, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2019

Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?

por Ma, Jie-Tao, Sun, Li, Sun, Xin, Xiong, Zhi-Cheng, Liu, Yang, Zhang, Shu-Ling, Huang, Le-Tian, Han, Cheng-Bo
Publicado 2017

Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis

por Cao, Rui, Ma, Jie‐Tao, Zhang, Shu‐Ling, Sun, Li, Liu, Yang, Zhang, Xiang‐Yan, Jing, Wei, Huang, Le‐Tian, Han, Cheng‐Bo
Publicado 2019

Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer Cells

por Ma, Jie-Tao, Zhang, Xiang-Yan, Cao, Rui, Sun, Li, Jing, Wei, Zhao, Jian-Zhu, Zhang, Shu-Ling, Huang, Le-Tian, Han, Cheng-Bo
Publicado 2019

Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

por Ma, Jie-Tao, Guo, Yi-Jia, Song, Jun, Sun, Li, Zhang, Shu-Ling, Huang, Le-Tian, Jing, Wei, Zhao, Jian-Zhu, Han, Cheng-Bo
Publicado 2021

Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report

por Huang, Le-Tian, Ma, Jie-Tao, Zhang, Shu-Ling, Li, Xiao-Han, Sun, Li, Jing, Wei, Zhao, Jian-Zhu, Wang, Yan-Ru, Han, Cheng-Bo
Publicado 2019

Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery

por Zhang, Shu-Ling, Song, Jun, Wang, Yan-Ru, Guo, Yi-Jia, Zhao, Jian-Zhu, Sun, Li, Huang, Le-Tian, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2021

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analys...

por Yi, Xiao-Fang, Song, Jun, Gao, Ruo-Lin, Sun, Li, Wu, Zhi-Xuan, Zhang, Shu-Ling, Huang, Le-Tian, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2022

Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis fro...

por Gao, Ruo-Lin, Song, Jun, Sun, Li, Wu, Zhi-Xuan, Yi, Xiao-Fang, Zhang, Shu-Ling, Huang, Le-Tian, Ma, Jie-Tao, Han, Cheng-Bo
Publicado 2022

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials

por Sun, Li, Guo, Yi-Jia, Song, Jun, Wang, Yan-Ru, Zhang, Shu-Ling, Huang, Le-Tian, Zhao, Jian-Zhu, Jing, Wei, Han, Cheng-Bo, Ma, Jie-Tao
Publicado 2021

Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cance...

por Huang, Le-Tian, Cao, Rui, Wang, Yan-Ru, Sun, Li, Zhang, Xiang-Yan, Guo, Yi-Jia, Zhao, Jian-Zhu, Zhang, Shu-Ling, Jing, Wei, Song, Jun, Han, Cheng-Bo, Ma, Jietao
Publicado 2021